Struggling with IgA Nephropathy?
A Clinical Research Study May Be an Option for You!
IgA Nephropathy (IgAN), also known as Berger’s disease, is a chronic kidney disorder caused by deposits of the antibody immunoglobulin A (IgA) building up in the kidneys. Over time, this leads to inflammation that damages kidney tissues and affects their ability to filter waste and excess fluids from the blood.
While some people with IgAN may experience mild symptoms for years, others may progress to kidney failure if the condition is left untreated. Common triggers and risk factors include genetic predisposition, infections, and autoimmune responses. Unfortunately, there is no cure yet, but new therapies are being investigated through IgA Nephropathy Clinical Trials to slow progression and improve patient outcomes.
You may be eligible for the IgA Nephropathy Clinical Trials if you are:
Eligibility criteria for heart failure clinical trials in Michigan:
- Are 18 years of age or older
- Have been diagnosed with IgA Nephropathy
*Additional criteria may apply.
Participation in IgA Nephropathy Clinical Trials includes access to study-related care, health assessments, investigational medication, and regular monitoring, completely free of charge, with no insurance required.
About the IgA Nephropathy Clinical Trials
At Revival Research Institute, we are conducting clinical trials focused on IgA nephropathy to evaluate the safety and effectiveness of investigational treatments. These studies may provide potential treatment options for patients at risk of progressive kidney damage by testing new approaches that aim to preserve kidney function.
Our trials are carried out under strict ethical and medical guidelines, with the goal of improving treatment options for IgA nephropathy and other chronic kidney diseases.
We are currently enrolling participants for IgA Nephropathy Clinical Trials. If you meet the eligibility criteria, you may gain access to study-related medical care, investigational medications, and health assessments at no cost.
*All volunteers who may be eligible for the research study will receive the study drug and study-related care, free of cost. And you may be compensated for your time and travel. No insurance is required to participate.
*Information shared during the phone screening process, and throughout the duration of the screening and study treatment will not be shared outside the organization. For more information, please read our Privacy Policy.
Get Started
What to Expect?
If you have IgA nephropathy, you may be eligible for clinical trial testing new treatment options. After you fill out the interest form above, someone from our research team will contact you for a short pre-screening to see if you meet the basic requirements.
If you qualify, we will ask you to review and sign an Informed Consent Form (ICF), which explains the study, including what’s involved, possible benefits, and risks.
After giving your consent, you’ll be invited to a screening visit at one of our clinical research sites. During this visit, we will go over your medical history, do a physical exam, and run some lab tests to confirm eligibility.
Our research team will guide you through every step and make sure you fully understand what participation involves. You will have the chance to ask any questions before deciding to join. By taking part, you are helping advance research that could improve future treatment for IgA nephropathy.
Age
18 years of age or older
Condition
IgA Nephropathy (Berger’s Disease)
Location
Texas
The Importance of IgA Nephropathy Clinical Trials
Chronic kidney disease impacts millions globally, and IgA Nephropathy is one of the leading causes. Because it can progress silently, early detection and new therapies are critical to slowing its course.
By joining IgA Nephropathy Clinical Trials at Revival Research Institute, you are not only accessing potential treatments, but you are also contributing to innovative research that could improve kidney care for future generations.
IgA Nephropathy May Be Triggered By
- Genetic factors or family history
- Abnormal immune responses
- Repeated infections (such as respiratory or gastrointestinal infections)
- Autoimmune conditions
Common Symptoms of IgA Nephropathy
- Blood in urine (hematuria), often after infections
- Foamy urine (indicating protein leakage)
- Swelling in hands, feet, or ankles (edema)
- High blood pressure (hypertension)
- Fatigue and weakness
Frequently Asked Questions
Got Questions About IgA Nephropathy? We've got the answers.
Here are answers to some of the most frequently asked questions about IgA nephropathy. Can’t find what you’re looking for? Give our friendly team a call at +1 (248) 721-9539. We’re happy to help.
